Double-digit Revenue Growth Till 2030 Drives BioMarin’s (BMRN) Bullish Thesis

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is 1 of the 10 Cheap Stocks with Huge Upside Potential. On January 20, Canaccord Genuity raised BioMarin Pharmaceutical Inc.’s (NASDAQ:BMRN) terms people from $84 to $98, implying 74.4% upside from the existent stock price. On January 13, Wedbush expert Yun Zhong reaffirmed his Buy standing connected the banal portion maintaining a terms people of $94. Yun Zhong’s Buy standing is based connected respective factors that reenforce the company’s quality to present sustained semipermanent growth. BioMarin’s 2025 gross guidance is accordant with broader marketplace expectations and is supported by the management’s extremity of maintaining double-digit gross maturation into the 2030s.

The institution continues to fortify its enactment presumption successful achondroplasia done Voxzogo, benefitting from a wide label, beardown diligent adherence, aboriginal attraction initiative, and planetary reach. At the aforesaid time, the steadfast is pursuing further statement and denotation expansions successful hypochondroplasia and different skeletal disorders. Regulatory and ineligible efforts, including an sNDA for afloat support and strategies related to orphan exclusivity and competition, are intended to support and widen this competitory position.

Moreover, caller pipeline developments connection incremental upside, with BMN‑351 showing dose-responsive dystrophin look successful Duchenne muscular dystrophy and BMN‑333 advancing into Phase 2/3 development. In summation to Wedbush, Evercore ISI besides reaffirmed its Buy standing connected the banal and acceptable a terms people of $110 connected January 13.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) operates arsenic a biotechnology company. The institution is engaged successful the commercialization and improvement of therapies for life-threatening uncommon diseases and aesculapian conditions. Its products dwell of VIMIZIM, VOXZOGO, NAGLAZYME, and PALYNZIQ.

While we admit the imaginable of BMRN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy and 30 Most Fantastic Stocks Every Investor Should Pay Attention To.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.